Research ArticleSpondyloarthritis
Persistence to Biologic Therapy Among Patients With Ankylosing Spondylitis: An Observational Study Using the OPAL Dataset
Hedley Griffiths, Tegan Smith, Christopher Mack, Jo Leadbetter, Belinda Butcher, Mustafa Acar and Sabina Ciciriello
The Journal of Rheumatology February 2022, 49 (2) 150-156; DOI: https://doi.org/10.3899/jrheum.201551
Hedley Griffiths
1H. Griffiths, MBBS, FRACP, OPAL Rheumatology Ltd, Sydney, and Barwon Rheumatology Service, Geelong;
Tegan Smith
2T. Smith, PhD, OPAL Rheumatology Ltd, Sydney;
Christopher Mack
3C. Mack, MBBS, FRACP, OPAL Rheumatology Ltd, Sydney, and Coast Joint Care, Maroochydore;
Jo Leadbetter
4J. Leadbetter, PhD, A Stat, WriteSource Medical, Lane Cove;
Belinda Butcher
5B. Butcher, PhD, CMPP, A Stat, WriteSource Medical, Lane Cove, and University of New South Wales, Kensington;
Mustafa Acar
6M. Acar, PhD, Janssen-Cilag, Macquarie Park;
Sabina Ciciriello
7S. Ciciriello, MBBS, FRACP, PhD, OPAL Rheumatology Ltd, Sydney, and Royal Melbourne Hospital, Parkville, Australia.
In this issue
The Journal of Rheumatology
Vol. 49, Issue 2
1 Feb 2022
Persistence to Biologic Therapy Among Patients With Ankylosing Spondylitis: An Observational Study Using the OPAL Dataset
Hedley Griffiths, Tegan Smith, Christopher Mack, Jo Leadbetter, Belinda Butcher, Mustafa Acar, Sabina Ciciriello
The Journal of Rheumatology Feb 2022, 49 (2) 150-156; DOI: 10.3899/jrheum.201551
Persistence to Biologic Therapy Among Patients With Ankylosing Spondylitis: An Observational Study Using the OPAL Dataset
Hedley Griffiths, Tegan Smith, Christopher Mack, Jo Leadbetter, Belinda Butcher, Mustafa Acar, Sabina Ciciriello
The Journal of Rheumatology Feb 2022, 49 (2) 150-156; DOI: 10.3899/jrheum.201551